دوره 30، شماره 139 - ( 11-1400 )                   جلد 30 شماره 139 صفحات 189-185 | برگشت به فهرست نسخه ها

XML English Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohammadi-asl J, Shahbazian H, Jasemi Zergani F, Kheradmand A. Identification of a Novel CLCNKB Mutation in an Iranian Family with Bartter Syndrome Type 3.. J Adv Med Biomed Res 2022; 30 (139) :185-189
URL: http://journal.zums.ac.ir/article-1-6189-fa.html
Identification of a Novel CLCNKB Mutation in an Iranian Family with Bartter Syndrome Type 3.. Journal of Advances in Medical and Biomedical Research. 1400; 30 (139) :185-189

URL: http://journal.zums.ac.ir/article-1-6189-fa.html

Identification of a Novel CLCNKB Mutation in an Iranian Family with Bartter Syndrome Type 3.
چکیده:   (92527 مشاهده)

Bartter syndrome (BS) is a group of uncommon genetic disorders of reabsorption of salt in the cortical thick ascending limb (TAL) of the Henle's loop, typically distinguished by metabolic alkalosis, salt loss, hypokalemia, hyperreninemic hyperaldosteronism and normal blood pressure. Bartter syndrome type 3, recognized as a classic BS (CBS), occurs because of mutations in CLCNKB gene.
We enrolled one consanguineous Iranian family with one patient in our study. Targeted genomic capture and massively parallel sequencing (MPS) of all recognized genes responsible for BS subtypes 1–5 were carried out to recognize the genetic reasons of BS.
Here, we report the recognition of a novel homozygous frameshift mutation in the CLCNKB gene in an Iranian pedigree. The subjects were homozygous for a frameshift mutation (p.Gly662GlyfsX12) within CLCNKB gene that encodes the basolateral chloride voltage-gated channel Kb.
The identification of other causative mutations in CLCNKB gene additionally supports the important function of this gene in causing BS. To the best of our knowledge, this is a novel CLCNKB gene mutation in BS children.The accurate function of the CLCNKB Gly662GlyfsX12 mutation in the CBS pathogenesis  is still unknown.

متن کامل [PDF 335 kb]   (47137 دریافت)    
نوع مطالعه: گزارش موردی | موضوع مقاله: Medical Biology
دریافت: 1399/6/5 | پذیرش: 1399/12/13 | انتشار: 1400/11/11
فهرست منابع
1. Cunha TDS, Heilberg IP. Bartter syndrome: causes, diagnosis, and treatment. Int J NephrolRenovasc Dis. 2018;11:291-301. [DOI:10.2147/IJNRD.S155397] [PMID] [PMCID]
2. Yang X, Zhang G, Wang M, Yang H, Li Q. Bartter Syndrome type 3: Phenotype-genotype correlation and favorable response to ibuprofen. Front Pediatr. 2018;6:153. [DOI:10.3389/fped.2018.00153] [PMID] [PMCID]
3. Andrini O, Keck M, Briones R, Lourdel S, Vargas-Poussou R, Teulon J. ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3. Am J Physiol Renal Physiol. 2015;308(12):F1324-34. [DOI:10.1152/ajprenal.00004.2015] [PMID]
4. Castaño AG, de Nanclares GP, Madariaga L, et al. Genetics of type III Bartter syndrome in Spain, proposed diagnostic algorithm. PLoS One. 2013;8(9):e74673. [DOI:10.1371/journal.pone.0074673] [PMID] [PMCID]
5. Blackburn AT, Miller RK. Modeling congenital kidney diseases in Xenopuslaevis.Dis Model Mech. 2019;12(4).
6. Zelikovic I, Szargel R, Hawash A, et al. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int. 2003;63(1):24-32. [DOI:10.1046/j.1523-1755.2003.00730.x] [PMID]
7. Akil I, Ozen S, Kandiloglu AR, Ersoy B. A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis. ClinExpNephrol. 2010;14(3):278-82. [DOI:10.1007/s10157-009-0262-7] [PMID]
8. Zhu B, Jiang H, Cao M, Zhao X, Jiang H. A novel CLCNKB mutation in a Chinese girl with classic Bartter syndrome: a case report. BMC Med Genet. 2019;20(1):1-6. [DOI:10.1186/s12881-019-0869-9] [PMID] [PMCID]
9. Gil-Peña H, Garcia-Lopez E, Alvarez-Garcia O, et al. Alterations of growth plate and abnormal insulin-like growth factor I metabolism in growth-retarded hypokalemic rats: effect of growth hormone treatment. Am J Physiol Renal Physiol. 2009;297(3):F639-45. [DOI:10.1152/ajprenal.00188.2009] [PMID]
10. Jentsch TJ, Stein V, Weinreich F, Zdebik AA. Molecular structure and physiological function of chloride channels. Physiol Rev. 2002;82(2):503-68. [DOI:10.1152/physrev.00029.2001] [PMID]
11. Nozu K, Fu XJ, Nakanishi K, et al. Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR. Pediatr Res. 2007;62(3):364-9. [DOI:10.1203/PDR.0b013e318123fb90] [PMID]
12. Schlingmann KP, Konrad M, Jeck N, et al. Salt wasting and deafness resulting from mutations in two chloride channels. N Engl J Med. 2004;350(13):1314-9. [DOI:10.1056/NEJMoa032843] [PMID]
13. Seys E, Andrini O, Keck M, et al. Clinical and genetic spectrum of Bartter syndrome type 3. J Am SocNephrol. 2017;28(8):2540-52. [DOI:10.1681/ASN.2016101057] [PMID] [PMCID]
14. Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat ClinPractNephrol. 2008;4(10):560-7. [DOI:10.1038/ncpneph0912] [PMID]
15. Yu Y, Xu C, Pan X, et al. Identification and functional analysis of novel mutations of the CLCNKB gene in Chinese patients with classic Bartter syndrome. Clin Genet. 2010;77(2):155-62. [DOI:10.1111/j.1399-0004.2009.01288.x] [PMID]
بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به Journal of Advances in Medical and Biomedical Research می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb